PRELUDE CAPITAL MANAGEMENT, LLC - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A101. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2017$2,000
-60.0%
2,000
-81.0%
0.00%
-100.0%
Q4 2016$5,00010,500
+10400.0%
0.00%
Q2 2016$01000.00%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,178,440$5,338,0005.83%
GREAT POINT PARTNERS LLC 399,007$1,808,0001.25%
Camber Capital Management LP 1,790,000$8,109,0000.85%
MENORA MIVTACHIM HOLDINGS LTD. 1,041,078$4,716,0000.43%
FEDERATED HERMES, INC. 10,427,472$47,237,0000.18%
SILVERBACK ASSET MANAGEMENT LLC 272,200$1,233,0000.10%
Catalyst Capital Advisors LLC 30,000$136,0000.07%
OBERWEIS ASSET MANAGEMENT INC/ 54,200$246,0000.07%
Baillie Gifford 5,548,351$25,134,0000.06%
Fore Research & Management, LP 200,000$906,0000.06%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders